camcevi
accord healthcare s.l.u. - leuprorelin mesilate - neoplasie prostatiche - terapia endocrina - camcevi is indicated for the treatment of hormone dependent advanced prostate cancer and for the treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy.
eligard 7.5 mg poudre et solvant pour la préparation d'un dépôt de suspension injectable
eligard 22.5 mg pulver und lösungsmittel zur herstellung einer depot-injektionssuspension
eligard 22.5 mg poudre et solvant pour la préparation d'un dépôt de suspension injectable
eligard 45 mg pulver und lösungsmittel zur herstellung einer depot-injektionssuspension
eligard 45 mg poudre et solvant pour la préparation d'un dépôt de suspension injectable
polyversum
gowan italia s.r.l. - pythium oligandrum m1; - polvere bagnabile - 17.5 % i valori indicati sono per 100 g di prodotto. - fungicida
fatromectin 6mg/g polvere orale
eco animal health europe limited - ivermectina - ivermectina - 6 milligrammo/g, ivermectina - 6 mg/g - ivermectin
bavencio
merck europe b.v. - avelumab - tumori neuroendocrini - altri agenti antineoplastici, anticorpi monoclonali - bavencio è indicato come monoterapia per il trattamento di pazienti adulti con carcinoma a cellule di merkel metastatico (mcc). bavencio in combinazione con axitinib è indicato per il trattamento di prima linea di pazienti adulti con carcinoma renale avanzato (rcc). bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.
gadovist
bayer s.p.a. - gadobutrolo - gadobutrolo